Tiffany Yu-Tin Chen, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Calciphylaxis | 2 | 2018 | 129 | 0.640 |
Why?
|
| Carcinoma, Adenoid Cystic | 2 | 2017 | 263 | 0.580 |
Why?
|
| Angiodysplasia | 1 | 2017 | 22 | 0.570 |
Why?
|
| Oncogene Proteins v-myb | 1 | 2017 | 26 | 0.560 |
Why?
|
| Neuromuscular Agents | 1 | 2018 | 148 | 0.530 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2017 | 72 | 0.520 |
Why?
|
| Migraine with Aura | 1 | 2018 | 204 | 0.510 |
Why?
|
| Eye Neoplasms | 1 | 2017 | 306 | 0.480 |
Why?
|
| Lacrimal Apparatus | 1 | 2017 | 224 | 0.470 |
Why?
|
| Botulinum Toxins, Type A | 1 | 2018 | 238 | 0.470 |
Why?
|
| Blood Vessels | 1 | 2017 | 1110 | 0.390 |
Why?
|
| Proto-Oncogene Proteins B-raf | 1 | 2020 | 2059 | 0.350 |
Why?
|
| Laryngoplasty | 2 | 2017 | 53 | 0.270 |
Why?
|
| Skin | 1 | 2017 | 4503 | 0.220 |
Why?
|
| Thrombosis | 1 | 2017 | 2957 | 0.220 |
Why?
|
| Bicycling | 1 | 2023 | 177 | 0.190 |
Why?
|
| Neoplasms, Unknown Primary | 1 | 2021 | 102 | 0.170 |
Why?
|
| Privacy | 1 | 2021 | 233 | 0.160 |
Why?
|
| Synthetic Biology | 1 | 2021 | 187 | 0.160 |
Why?
|
| Thyroid Neoplasms | 2 | 2020 | 2360 | 0.140 |
Why?
|
| Immunohistochemistry | 3 | 2020 | 11095 | 0.130 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2021 | 709 | 0.130 |
Why?
|
| Walking | 1 | 2023 | 1201 | 0.130 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2017 | 243 | 0.120 |
Why?
|
| Biopsy | 2 | 2017 | 6793 | 0.120 |
Why?
|
| Mouth Neoplasms | 1 | 2020 | 597 | 0.120 |
Why?
|
| Recurrent Laryngeal Nerve | 1 | 2016 | 145 | 0.120 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2017 | 2521 | 0.110 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2020 | 4058 | 0.110 |
Why?
|
| Vocal Cord Paralysis | 1 | 2016 | 275 | 0.110 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2017 | 507 | 0.100 |
Why?
|
| Gene Rearrangement | 1 | 2017 | 1146 | 0.090 |
Why?
|
| Papillomaviridae | 1 | 2017 | 1140 | 0.090 |
Why?
|
| Image Interpretation, Computer-Assisted | 2 | 2021 | 3390 | 0.090 |
Why?
|
| Warfarin | 1 | 2018 | 1493 | 0.080 |
Why?
|
| Carcinoma, Renal Cell | 2 | 2021 | 3187 | 0.080 |
Why?
|
| Collagen | 1 | 2016 | 2643 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2020 | 2333 | 0.070 |
Why?
|
| Computer Simulation | 1 | 2021 | 6283 | 0.070 |
Why?
|
| Kidney Neoplasms | 2 | 2021 | 4282 | 0.070 |
Why?
|
| Tissue Engineering | 1 | 2017 | 1893 | 0.070 |
Why?
|
| Retrospective Studies | 5 | 2020 | 81762 | 0.070 |
Why?
|
| Artificial Intelligence | 1 | 2021 | 2665 | 0.070 |
Why?
|
| Middle Aged | 7 | 2020 | 223492 | 0.070 |
Why?
|
| Papillomavirus Infections | 1 | 2017 | 1640 | 0.060 |
Why?
|
| Aged, 80 and over | 3 | 2020 | 59629 | 0.060 |
Why?
|
| Kidney Failure, Chronic | 1 | 2017 | 2496 | 0.060 |
Why?
|
| Diagnosis, Differential | 1 | 2020 | 13014 | 0.060 |
Why?
|
| Injections | 2 | 2017 | 840 | 0.060 |
Why?
|
| Male | 8 | 2021 | 364719 | 0.050 |
Why?
|
| Female | 9 | 2021 | 397192 | 0.050 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 2931 | 0.050 |
Why?
|
| Delivery of Health Care | 1 | 2021 | 5367 | 0.050 |
Why?
|
| Cohort Studies | 3 | 2021 | 41754 | 0.050 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2021 | 5432 | 0.050 |
Why?
|
| Adult | 6 | 2020 | 223646 | 0.050 |
Why?
|
| Anticoagulants | 1 | 2018 | 4852 | 0.050 |
Why?
|
| Aged | 6 | 2020 | 171504 | 0.050 |
Why?
|
| Histological Techniques | 1 | 2021 | 194 | 0.050 |
Why?
|
| Transportation | 1 | 2023 | 217 | 0.050 |
Why?
|
| Information Theory | 1 | 2021 | 49 | 0.050 |
Why?
|
| Algorithms | 1 | 2021 | 14164 | 0.050 |
Why?
|
| Humans | 13 | 2023 | 768166 | 0.050 |
Why?
|
| Geographic Information Systems | 1 | 2023 | 283 | 0.040 |
Why?
|
| Rabbits | 2 | 2017 | 4772 | 0.040 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 15948 | 0.040 |
Why?
|
| Histocytochemistry | 1 | 2021 | 699 | 0.040 |
Why?
|
| Adolescent | 2 | 2018 | 89169 | 0.040 |
Why?
|
| Quality Control | 1 | 2021 | 836 | 0.040 |
Why?
|
| Mitotic Index | 1 | 2017 | 162 | 0.040 |
Why?
|
| Area Under Curve | 1 | 2021 | 1643 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2021 | 13586 | 0.030 |
Why?
|
| Workflow | 1 | 2021 | 860 | 0.030 |
Why?
|
| Microscopy | 1 | 2021 | 909 | 0.030 |
Why?
|
| Mutation | 1 | 2020 | 30238 | 0.030 |
Why?
|
| Thrombophilia | 1 | 2018 | 308 | 0.030 |
Why?
|
| Neoplasm Staging | 2 | 2020 | 11244 | 0.030 |
Why?
|
| Young Adult | 2 | 2020 | 60066 | 0.030 |
Why?
|
| Necrosis | 1 | 2017 | 1616 | 0.030 |
Why?
|
| Lymphatic Metastasis | 1 | 2021 | 2914 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2020 | 3620 | 0.020 |
Why?
|
| Laryngoscopy | 1 | 2017 | 714 | 0.020 |
Why?
|
| Reference Values | 1 | 2018 | 4938 | 0.020 |
Why?
|
| Neoplasm Metastasis | 1 | 2021 | 4912 | 0.020 |
Why?
|
| Risk Factors | 1 | 2017 | 74944 | 0.020 |
Why?
|
| RNA, Viral | 1 | 2017 | 2872 | 0.020 |
Why?
|
| Child | 1 | 2017 | 80917 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2017 | 6082 | 0.020 |
Why?
|
| Prognosis | 2 | 2020 | 30010 | 0.020 |
Why?
|
| Disease Models, Animal | 2 | 2017 | 18349 | 0.020 |
Why?
|
| Diagnostic Imaging | 1 | 2021 | 3533 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2021 | 14729 | 0.020 |
Why?
|
| Sex Factors | 1 | 2018 | 10632 | 0.010 |
Why?
|
| Reproducibility of Results | 1 | 2021 | 20227 | 0.010 |
Why?
|
| Cell Proliferation | 1 | 2017 | 10474 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2020 | 9419 | 0.010 |
Why?
|
| Age Factors | 1 | 2018 | 18412 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2017 | 11669 | 0.010 |
Why?
|
| Phenotype | 1 | 2017 | 16726 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2018 | 24315 | 0.010 |
Why?
|
| Animals | 2 | 2017 | 169246 | 0.010 |
Why?
|
| United States | 1 | 2023 | 73039 | 0.010 |
Why?
|
| Time Factors | 1 | 2016 | 40218 | 0.010 |
Why?
|